Skip to main content

Obsidian Therapeutics, Inc.

OBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002130606

No open-market purchases or sales by Obsidian Therapeutics, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Members of Congress who traded OBX

No member of Congress has reported a trade in Obsidian Therapeutics, Inc. since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.